JPWO2020123952A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020123952A5 JPWO2020123952A5 JP2021533470A JP2021533470A JPWO2020123952A5 JP WO2020123952 A5 JPWO2020123952 A5 JP WO2020123952A5 JP 2021533470 A JP2021533470 A JP 2021533470A JP 2021533470 A JP2021533470 A JP 2021533470A JP WO2020123952 A5 JPWO2020123952 A5 JP WO2020123952A5
- Authority
- JP
- Japan
- Prior art keywords
- dispersion
- disorder
- tosylate
- iti
- dioxane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862779930P | 2018-12-14 | 2018-12-14 | |
| US62/779,930 | 2018-12-14 | ||
| PCT/US2019/066247 WO2020123952A1 (en) | 2018-12-14 | 2019-12-13 | Amorphous solid dispersions |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022512239A JP2022512239A (ja) | 2022-02-02 |
| JPWO2020123952A5 true JPWO2020123952A5 (https=) | 2022-12-14 |
| JP2022512239A5 JP2022512239A5 (https=) | 2022-12-14 |
| JP7523440B2 JP7523440B2 (ja) | 2024-07-26 |
Family
ID=71077112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021533470A Active JP7523440B2 (ja) | 2018-12-14 | 2019-12-13 | アモルファス固体分散体 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP3893878A4 (https=) |
| JP (1) | JP7523440B2 (https=) |
| KR (1) | KR20210103501A (https=) |
| CN (1) | CN113473988A (https=) |
| AU (1) | AU2019398451B2 (https=) |
| CA (1) | CA3123085A1 (https=) |
| IL (1) | IL283927A (https=) |
| MX (1) | MX2021006886A (https=) |
| WO (1) | WO2020123952A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112584837A (zh) * | 2018-08-31 | 2021-03-30 | 细胞内治疗公司 | 新方法 |
| CN115671057A (zh) | 2022-10-19 | 2023-02-03 | 四川迈可隆生物科技有限公司 | 一种卢美哌隆药物组合物、长效微球缓释制剂及其制备方法 |
| CN118566395B (zh) * | 2024-08-02 | 2024-10-25 | 则正(济南)生物科技有限公司 | 测定甲苯磺酸卢美哌隆口崩片中杂质含量的方法、应用和系统 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4001281A1 (en) * | 2016-08-09 | 2022-05-25 | Teva Pharmaceuticals International GmbH | Solid state forms of lumateperone ditosylate salt and preparation thereof |
| US11331316B2 (en) * | 2016-10-12 | 2022-05-17 | Intra-Cellular Therapies, Inc. | Amorphous solid dispersions |
| JP2020513023A (ja) * | 2017-04-10 | 2020-04-30 | ドクター・レディーズ・ラボラトリーズ・リミテッド | ルマテペロンｐ−トシラートの非晶質形態および固体分散体 |
| US11655251B2 (en) * | 2017-11-27 | 2023-05-23 | Egis Gyogyszergyar Zrt. | Method for the production of lumateperone and its salts |
| CN112584837A (zh) * | 2018-08-31 | 2021-03-30 | 细胞内治疗公司 | 新方法 |
-
2019
- 2019-12-13 MX MX2021006886A patent/MX2021006886A/es unknown
- 2019-12-13 CN CN201980092118.2A patent/CN113473988A/zh active Pending
- 2019-12-13 JP JP2021533470A patent/JP7523440B2/ja active Active
- 2019-12-13 AU AU2019398451A patent/AU2019398451B2/en active Active
- 2019-12-13 KR KR1020217021918A patent/KR20210103501A/ko active Pending
- 2019-12-13 EP EP19897052.7A patent/EP3893878A4/en active Pending
- 2019-12-13 CA CA3123085A patent/CA3123085A1/en active Pending
- 2019-12-13 WO PCT/US2019/066247 patent/WO2020123952A1/en not_active Ceased
-
2021
- 2021-06-13 IL IL283927A patent/IL283927A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN114845709A (zh) | 用于治疗炎性病症的mrgprx2拮抗剂 | |
| TWI522100B (zh) | 含有納布啡（ｎａｌｂｕｐｈｉｎｅ）之藥學組成物及其用途 | |
| US12128027B2 (en) | N—N-dimethyltryptamine (DMT) and DMT analog compositions, methods of making, and methods of use thereof | |
| EP3785698B1 (en) | Edaravone pharmaceutical composition | |
| JP7846211B2 (ja) | 治療適用のためのｄ－リゼルグ酸ジエチルアミドの即時放出製剤 | |
| JP2021505575A (ja) | 非ラセミ混合物およびその使用 | |
| FI3856341T3 (fi) | (s)-1-(4-fluorifenyyli)-1-(2-(4-(6-(1-metyyli-1h-pyratsol-4-yyli)pyrrolo[2,1-f][1,2,4]triatsin-4-yyli)piperatsinyyli)pyrimidin-5-yyli)etaani-1-amiinin kidemuotoja ja valmistusmenetelmiä | |
| RS64477B1 (sr) | Novi derivati ftalazinona i postupak njihove proizvodnje | |
| EP4434513A1 (en) | Nanocrystalline preparation of rock2 inhibitor and preparation method therefor | |
| KR20170083509A (ko) | 바레니클린 또는 이의 약학적으로 허용가능한 염을 함유하는 맛 차폐된 구강 투여용 약학 제제 | |
| CN114728919A (zh) | MrgprX2拮抗剂及其用途 | |
| TW201444589A (zh) | 錠劑型式 | |
| ES2384333T3 (es) | Composiciones farmacéuticas que tienen perfiles de disolución mejorados para fármacos poco solubles | |
| JP2018516942A (ja) | 生体利用率が改善された含プランルカスト固形製剤の組成物及びその製造方法 | |
| JP2008501778A (ja) | 疼痛の治療のためのレボキセチンの使用 | |
| JPWO2020123952A5 (https=) | ||
| JP6400121B2 (ja) | 医療用のピルリンドールエナンチオマーの薬学的に許容可能な塩 | |
| WO2009123169A1 (ja) | アミド誘導体含有医薬組成物 | |
| JP2023050190A (ja) | アピキサバン含有口腔内崩壊錠、及びその製造方法 | |
| CN108024964B (zh) | 用于治疗hcv的固体药物组合物 | |
| WO2013100878A1 (en) | Pharmaceutical formulations comprising aripiprazole | |
| KR101125210B1 (ko) | 아리피프라졸-벤토나이트-ａｅａ 혼성체, 이를 함유하는 약학 조성물 및 그 제조방법 | |
| JPWO2006080312A1 (ja) | 吸着多孔体の製造法 | |
| US20240383892A1 (en) | PARTICLES OF IMIDAZO[4,5-b]PYRIDINE COMPOUND, PHARMACEUTICAL COMPOSITIONS, AND THEIR USE IN TREATING MEDICAL CONDITIONS | |
| WO2005016315A1 (en) | Pharmaceutical compositions of nateglinide and a high amount of a water-soluble filler |